methamphetamine and tak-063

methamphetamine has been researched along with tak-063 in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	2 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Harada, A; Kimura, H; Miyamoto, M; Suzuki, H; Suzuki, K	1
Capuani, C; Corsi, M; Harada, A; Kimura, H; Suzuki, H; Suzuki, K; Ugolini, A	1

Other Studies

2 other study(ies) available for methamphetamine and tak-063

Article	Year
TAK-063, a PDE10A Inhibitor with Balanced Activation of Direct and Indirect Pathways, Provides Potent Antipsychotic-Like Effects in Multiple Paradigms. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2016, Volume: 41, Issue:9 Topics: Animals; Antipsychotic Agents; Brain; Corpus Striatum; Cyclic AMP; Cyclic GMP; Dizocilpine Maleate; Dopamine; Dose-Response Relationship, Drug; Hyperkinesis; Male; Methamphetamine; Mice, Inbred C57BL; Phosphodiesterase Inhibitors; Phosphoric Diester Hydrolases; Prepulse Inhibition; Pyrazoles; Pyridazines; Quinolines; Rats, Sprague-Dawley	2016
Combined treatment with a selective PDE10A inhibitor TAK-063 and either haloperidol or olanzapine at subeffective doses produces potent antipsychotic-like effects without affecting plasma prolactin levels and cataleptic responses in rodents. Pharmacology research & perspectives, 2018, Volume: 6, Issue:1 Topics: Administration, Oral; Akathisia, Drug-Induced; Animals; Antipsychotic Agents; Benzodiazepines; Catalepsy; Corpus Striatum; Dendritic Spines; Disease Models, Animal; Dopamine Antagonists; Drug Synergism; Drug Therapy, Combination; Haloperidol; Humans; Male; Methamphetamine; Mice; Mice, Inbred ICR; Neurons; Olanzapine; Phosphodiesterase Inhibitors; Prolactin; Pyrazoles; Pyridazines; Rats; Rats, Sprague-Dawley; Synaptic Potentials; Treatment Outcome	2018

Article

Year

TAK-063, a PDE10A Inhibitor with Balanced Activation of Direct and Indirect Pathways, Provides Potent Antipsychotic-Like Effects in Multiple Paradigms.

Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2016, Volume: 41, Issue:9

Topics: Animals; Antipsychotic Agents; Brain; Corpus Striatum; Cyclic AMP; Cyclic GMP; Dizocilpine Maleate; Dopamine; Dose-Response Relationship, Drug; Hyperkinesis; Male; Methamphetamine; Mice, Inbred C57BL; Phosphodiesterase Inhibitors; Phosphoric Diester Hydrolases; Prepulse Inhibition; Pyrazoles; Pyridazines; Quinolines; Rats, Sprague-Dawley

2016

Combined treatment with a selective PDE10A inhibitor TAK-063 and either haloperidol or olanzapine at subeffective doses produces potent antipsychotic-like effects without affecting plasma prolactin levels and cataleptic responses in rodents.

Pharmacology research & perspectives, 2018, Volume: 6, Issue:1

Topics: Administration, Oral; Akathisia, Drug-Induced; Animals; Antipsychotic Agents; Benzodiazepines; Catalepsy; Corpus Striatum; Dendritic Spines; Disease Models, Animal; Dopamine Antagonists; Drug Synergism; Drug Therapy, Combination; Haloperidol; Humans; Male; Methamphetamine; Mice; Mice, Inbred ICR; Neurons; Olanzapine; Phosphodiesterase Inhibitors; Prolactin; Pyrazoles; Pyridazines; Rats; Rats, Sprague-Dawley; Synaptic Potentials; Treatment Outcome

2018